Telemedicine-delivered Digital Cognitive Behavioral Intervention to Decrease Post-operative Opioid Use Among Patients Undergoing Total Knee or Hip Arthroplasty

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Adults \>18 years

• Scheduled for elective primary total knee arthroplasty (TKA) or hip replacement (THA) at the approved UPMC hospitals

• Moderately high levels of mood disorder symptoms on validated PROMIS measures, defined as a T-score \> or = to 60 on PROMIS Anxiety 4a short form and/or PROMIS Depression4a short form

Locations
United States
Pennsylvania
UPMC East
RECRUITING
Monroeville
UPMC Passavant
RECRUITING
Pittsburgh
UPMC Shadyside
RECRUITING
Pittsburgh
Contact Information
Primary
Ata Murat Kaynar, MD, MPH
kaynarm@upmc.edu
412-383-3463
Backup
Carly Riedmann, MPH
riedmannca@upmc.edu
412-623-4147
Time Frame
Start Date: 2023-01-27
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 150
Treatments
Active_comparator: Control
No intervention (No RxWell). Subjects will receive standard of care and education regarding potential resources for anxiety and depression. Subjects will complete questionnaires via REDCap assessing primary and secondary outcomes
Experimental: Intervention: RxWell
RxWell Intervention. Subjects will receive standard of care and digital cognitive behavioral intervention by using the application RxWell. Subjects will complete questionnaires via REDCap assessing primary and secondary outcomes and will complete GAD-7 (Generalized Anxiety Disorder Scale) and PHQ-8 (Patient Health Questionnaire for Depression) every 2 weeks within the RxWell application.
No_intervention: Control (screen failures)
We will collect data on patient outcomes for patients that did not meet criteria for the RxWell intervention.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Leads: University of Pittsburgh

This content was sourced from clinicaltrials.gov